⚠ Disque-IntoxicaΓ§Γ£o: 0800 722 6001  |  SAMU: 192  |  Bombeiros: 193

About This Guide

This guide covers the most clinically significant toxic mushroom species documented in Brazil: the lethal Amanita phalloides (Death Cap) in the subtropical Atlantic Forest and Pampas; the suspected-lethal Amanita campinaranae endemic to the Amazon Rainforest; and the gastrointestinal toxin producer Chlorophyllum molybdites ubiquitous across urban and Cerrado/Caatinga environments. Species data are organized by ecological biome and documented range.

Data-only reference β€” no photographs. Species identification for clinical management must be confirmed by a toxicologist, mycologist, or poison control specialist, not from this text alone.

Quick Reference β€” All Species

SpeciesTierToxin ClassOnsetPrimary Risk
Amanita phalloides Tier 1 Amatoxins (heat-stable bicyclic octapeptides) Biphasic/triphasic: 6–24 h Fulminant hepatic necrosis, death
Amanita campinaranae Tier 1 Suspected amatoxins (morphology-based) 6–12 hours Suspected fulminant hepatic necrosis, death
Chlorophyllum molybdites Tier 2 Leucoagaricitin (heat-labile GI protein toxin) 30 min–2.5 hours Severe GI illness; resolves in 24–48 h
☎ Emergency Contacts β€” Brazil

National Emergency Numbers

Disque-IntoxicaΓ§Γ£o (ANVISA National Poison Control)
0800 722 6001
24/7 β€” Toll-free
SAMU (Emergency Medical Services)
192
24/7
Bombeiros (Fire and Wilderness Rescue)
193
24/7

Regional CIATox / CIT Centers

SΓ£o Paulo HC-USP
(11) 2661-8571
(11) 2661-8800
24/7
SΓ£o Paulo Unicamp
(19) 3521-7555
24/7
Rio Grande do Sul CIT-RS
0800 721 3000
(51) 2139-9200
24/7
Minas Gerais β€” Hospital JoΓ£o XXIII
(31) 3239-9308
(31) 3239-9390
(31) 3239-9275
24/7
Amazonas β€” FMT-HVD
(92) 2127-3432
(92) 2127-3532
24/7
⚠ Telephone routing changes β€” verify all numbers are currently active before relying on them in the field.
⬑ Triage Algorithm & Bedside Decision Matrix

ONSET BRANCH β€” Two Primary Decision Paths

πŸ”΄ LATE ONSET β€” Over 6 Hours

Presumptive amatoxin. Initiate full Tier 1 ICU protocol immediately. Do NOT await laboratory confirmation in Amazonian remote settings. Admit all patients for 96-hour monitoring minimum.

🟑 EARLY ONSET β€” Under 6 Hours

Likely GI irritant (Tier 2). Supportive care with IV rehydration and antiemetics. Observe minimum 6 hours. If late symptoms develop, escalate immediately to Tier 1 protocol.

Bedside Decision Matrix β€” All Species

Species Onset Initial Symptom Pattern Immediate Action Disposition
A. phalloides β€” Death Cap 6–24 h Apparent recovery after initial GI; then rapidly rising AST/ALT, coagulopathy, encephalopathy Admit ICU. IV silibinin + NAC + MDAC. Hepatology + transplant consult. ICU admission. Liver transplant unit notification.
A. campinaranae β€” Amazonian Amanita 6–12 h Nausea, vomiting, abdominal pain followed by apparent latent period; hepatic injury expected Treat as full amatoxin without awaiting labs. Dual large-bore IV access. Activate transfer protocol. ICU admission. Urgent transfer if tertiary center available.
C. molybdites β€” False Parasol 30 min–2.5 h Profuse vomiting and diarrhea. No hepatic involvement. Resolves in 24–48 h. IV ondansetron or metoclopramide. IV crystalloid. Electrolyte panel. Do NOT administer loperamide or diphenoxylate. ED observation minimum 6 h; discharge with oral rehydration if stable.
☠ Tier 1 β€” Amanita phalloides β€” Subtropical Atlantic Forest and Pampas
Amanita phalloides (Vaill. ex Fr.) Link
Death Cap Β· Cicuta verde Β· Anjo da morte
Brazilian States
RS, SC, PR, high-altitude SP
Biome
Subtropical Atlantic Forest, Pampas
Fruiting Season
April to July
Symptom Onset
6–24 hours β€” biphasic/triphasic
Voucher Herbarium
HerbΓ‘rio da Universidade Federal do Rio Grande do Sul (ICN)
Tier Classification
Tier 1 β€” Lethal
⚠ LETHAL β€” Amatoxin-containing. Heat-stable. Survives cooking. Treat ALL suspected ingestions as toxicological emergencies regardless of symptom severity at presentation.

Full ICU Treatment Protocol

  1. Aggressive IV hydration β€” crystalloid resuscitation; target euvolemia with strict fluid balance monitoring
  2. Multidose activated charcoal (MDAC) via nasogastric tube β€” interrupts enterohepatic recycling of amatoxins
  3. IV Silibinin (Legalon SIL) β€” four consecutive uninterrupted 6-hour infusion blocks with zero gap between bags to maintain continuous OATP1B3 receptor blockade; any gap breaks receptor saturation
  4. IV N-acetylcysteine (NAC) β€” three-bag regimen:
    • 150 mg/kg over 1 hour (loading dose)
    • 50 mg/kg over 4 hours
    • 100 mg/kg over 16 hours
    • Then repeat at 150 mg/kg every 24 hours until INR drops below 1.5 AND transaminases clear linearly
  5. TGO/TGP (AST/ALT) and INR monitoring every 6 hours
  6. Early liver transplant unit notification β€” do not wait for confirmed hepatic failure to initiate contact

King's College Criteria β€” Non-Paracetamol (Toxic Mushroom Thresholds)

Single criterion (any one alone sufficient):

  • Arterial pH below 7.3 after adequate resuscitation

Multi-factor criteria (any three of the five simultaneously):

  • INR above 3.5
  • Bilirubin above 300 Β΅mol/L
  • Age under 10 or over 40
  • Jaundice to encephalopathy interval greater than 7 days
  • Confirmed toxic mushroom ingestion

When criteria are met, immediate listing for emergency liver transplant is indicated. Do not delay notification pending additional deterioration.

Meixner Test β€” Bedside Amatoxin Screen

Procedure:

  1. Place a drop of fresh mushroom juice (or aqueous extract) on plain white newsprint or filter paper containing lignin
  2. Allow to dry completely at room temperature β€” do NOT apply heat
  3. Apply one drop of 10% hydrochloric acid (HCl)
  4. A blue coloration within 1–3 minutes indicates a positive result β€” presumptive amatoxin present

Limitations: Psilocybin and some other indole compounds also produce a blue color (false positive). The test cannot detect amatoxins below the colorimetric threshold.

🚨 CRITICAL SAFETY WARNING: A NEGATIVE MEIXNER TEST RESULT CANNOT EXCLUDE AMATOXIN POISONING. This test has documented false-negative results. Never use the Meixner test as the sole criterion to discharge a patient with suspected mushroom ingestion. Clinical triage must be biomarker-driven. Proceed with laboratory amatoxin testing and clinical monitoring regardless of Meixner result.

Diagnostic Sampling

Gastric Aspirate ELISA: Collect via nasogastric tube within the first 6 hours for patients who ingested cooked specimens. Amatoxins are heat-stable and survive cooking β€” confirmatory ELISA remains valid even when no physical mushroom material remains.
Urine Amatoxin Testing: Optimal sensitivity within 48 hours of ingestion. Sensitivity drops markedly after 72 hours due to hepatic trapping of amatoxins in injured hepatocytes. Collect urine specimens as early as possible.

Pediatric Dosing Protocol

Pediatric Adjustments

  • Activated charcoal: 1 g/kg every 4 hours via nasogastric tube
  • NAC and Silibinin: weight-based dosing β€” consult pediatric toxicology for precise calculation
  • IV fluid resuscitation: conservative at 1.0–1.5 mL/kg/hour with strict fluid balance monitoring every 2 hours β€” do not exceed to prevent pulmonary edema in small children

πŸ• Veterinary β€” Dogs

Clinical signs: Vomiting, diarrhea (may be hemorrhagic), lethargy, abdominal pain, jaundice, ascites, hepatic encephalopathy, coagulopathy. Onset typically 6–24 hours after ingestion.

Treatment protocol:

  • IV N-acetylcysteine: 140 mg/kg loading dose, then 70 mg/kg every 4 hours for 17 doses
  • Multidose activated charcoal (MDAC) if within 2–4 hours of ingestion and patient is not vomiting uncontrollably
  • Aggressive IV fluid support with crystalloids; monitor renal output
  • Serial hepatic panel (ALT, AST, ALP, bilirubin) and renal panel (BUN, creatinine) every 6–12 hours
  • Vitamin K1 if coagulopathy present
  • Referral to veterinary internal medicine or emergency specialist if available

Prognosis: Guarded to poor without aggressive early treatment. Mortality is significant in delayed presentations. Prognosis worsens with onset of clinical jaundice and hepatic encephalopathy.

🐈 Veterinary β€” Cats

Clinical signs: Vomiting, diarrhea, lethargy, inappetence, icterus, hepatic encephalopathy. Cats may present with less overt GI signs than dogs early in the course.

Treatment:

  • SAMe (S-adenosylmethionine) as hepatoprotectant β€” 20 mg/kg orally once daily
  • N-acetylcysteine at weight-based dosing; consult veterinary formulary
  • Thermal support β€” cats are prone to hypothermia in hepatic failure
  • IV fluid support; cats tolerate aggressive fluid loading poorly β€” conservative resuscitation preferred
  • Avoid drugs with high hepatic metabolism (acetaminophen absolutely contraindicated)

Prognosis: Guarded to poor. Cats are particularly susceptible to hepatotoxic injury. Early intervention is critical.

☠ Tier 1 β€” Amanita campinaranae β€” Amazon Rainforest
Amanita campinaranae Wartchow
Amazonian White Amanita Β· Amanita da AmazΓ΄nia
Brazilian States
AM, PA, AP
Biome
Amazon Rainforest (campinarana white-sand forest)
Fruiting Season
January to May
Symptom Onset
6–12 hours
Classification
Suspected lethal β€” amatoxin class based on morphology and toxin class inference
Voucher Herbarium
HerbΓ‘rio do Instituto Nacional de Pesquisas da AmazΓ΄nia (INPA)
⚠ SUSPECTED LETHAL β€” Zero-tolerance amatoxin protocol. Apply full Tier 1 treatment without waiting for laboratory confirmation. In remote Amazonian settings, treat on clinical history alone.

ICU Treatment Protocol

  • Zero-tolerance amatoxin rules: apply full Tier 1 amatoxin protocol immediately without awaiting laboratory confirmation
  • Dual large-bore IV access mandatory β€” establish before any other intervention
  • Euvolemic targeted fluid resuscitation with CVP monitoring titrated hourly β€” do NOT use aggressive fluid loading; this species is under-studied and renal involvement cannot be excluded
  • Activated charcoal via nasogastric tube β€” multidose regimen as per Tier 1 protocol above
  • Serial hepatic and renal monitoring β€” AST, ALT, creatinine, INR every 6 hours
  • Early transfer to tertiary center if available β€” Amazonian region has limited specialist toxicology access
Brazil-Specific Access Warning: The CIATox network is well-developed in southeast Brazil but the Amazonian region (AM, PA, AP) has significantly limited specialist toxicology access. In remote Amazonian settings, treat on clinical history alone without waiting for laboratory confirmation. Activate the FMT-HVD Manaus line early: (92) 2127-3432.

πŸ•πŸˆ Veterinary β€” Dogs and Cats

Treat under the full amatoxin protocol as detailed above for Amanita phalloides. Given the remote Amazonian setting where access to veterinary specialists may be severely limited, prioritize aggressive supportive care, IV NAC, and MDAC. Contact the nearest veterinary emergency center by telephone for real-time dosing guidance.

⚠ Tier 2 β€” Chlorophyllum molybdites β€” Cerrado, Caatinga, and Urban
Chlorophyllum molybdites (G. Mey.) Massee
False Parasol Β· Cogumelo-de-esporas-verdes
Brazilian States
DF, MG, SP, RJ β€” ubiquitous across urban lawns and parks
Biome
Cerrado, Caatinga, urban environments
Fruiting Season
Spring to Autumn; year-round during rainy windows
Symptom Onset
30 minutes to 2.5 hours
Active Toxin
Leucoagaricitin β€” high-molecular-weight heat-labile toxic protein
Global Distribution
Six continents (Antarctica excluded)
Voucher Herbarium
HerbΓ‘rio do Instituto de BotΓ’nica (SP)
β›” DO NOT administer Loperamide or Diphenoxylate β€” halting diarrhea traps the irritating protein toxin inside the gastrointestinal tract and worsens the clinical picture.

Treatment Protocol

  • IV Ondansetron or Metoclopramide for emesis control
  • Aggressive IV crystalloid rehydration
  • Electrolyte panels β€” monitor for hyponatremia and hypokalemia from fluid losses
  • Fully resolves in 24–48 hours with supportive care β€” no hepatic involvement expected
  • Observe minimum 6 hours; discharge when tolerating oral fluids
Toxin nomenclature note: The active toxin in C. molybdites is Leucoagaricitin, a high-molecular-weight heat-labile protein. The term "molybdotoxin" is a fabricated designation that does not appear in the peer-reviewed literature and must not be used in clinical documentation.

πŸ• Veterinary β€” Dogs

Clinical signs: Profuse vomiting, watery to hemorrhagic diarrhea, lethargy, abdominal discomfort. Onset within 30 minutes to 2 hours of ingestion.

Treatment: IV fluids (crystalloid), antiemetics (maropitant or ondansetron), electrolyte monitoring. Do NOT administer antidiarrheal agents (loperamide).

Prognosis: Good with supportive care. Most dogs recover within 24–48 hours. Monitor for dehydration and electrolyte disturbance in small-breed dogs.

🐈 Veterinary β€” Cats

Clinical signs: Vomiting, diarrhea, lethargy. Cats are less likely than dogs to ingest large quantities but toxicity is confirmed.

Treatment: IV fluid support, antiemetics, monitoring. Supportive care only.

Prognosis: Good with supportive care. Full recovery expected in 24–48 hours.

πŸ“‹ Clinical Case Intake Protocol

Demographics

Location and Biome

Timeline

Preparation Method and Detoxifying Myths

Sample Preservation Protocol

Diagnostic Sampling

Brazil-Specific Regional Access Note

πŸ“± QR Code β€” Share This Guide

Scan to open this guide on any device

https://www.sporeandscout.com/guides/toxic-mushroom-clinical-reference-brazil

This QR code links to: https://www.sporeandscout.com/guides/toxic-mushroom-clinical-reference-brazil

Clinical Disclaimer: This guide is intended as a supplementary reference tool for licensed healthcare professionals. It does not constitute medical advice and does not replace clinical judgment, institutional protocols, or direct consultation with a certified poison control center or toxicologist. Species identification must be confirmed by a qualified mycologist or toxicologist. All treatment decisions must be made by a licensed physician based on the individual patient's presentation. Dosing recommendations reflect current literature at time of publication β€” verify against current references before clinical use. Spore & Scout bears no liability for clinical outcomes based on use of this reference.